Bionano Genomics Inc (NASDAQ:BNGO)
| 0.618 Delayed Data As of Sep 17 |  +0.0399 / +6.76%Today’s Change | 0.25 Today|||52-Week Range 4.70 | -50.16% Year-to-Date |
Latest BNGO News | Press Releases
| Bionano Genomics: Intriguing Technology. Troubling Trajectory Sep 08 / Seeking Alpha - Paid Partner Content | Bionano Saphyr’s enters clinical laboratory for genome imaging Aug 20 / Seeking Alpha - Paid Partner Content |
| Bionano Genomics names new finance executive Aug 26 / Seeking Alpha - Paid Partner Content | Bionano's Saphyr enters clinical laboratory for genome imaging Aug 20 / Seeking Alpha - Paid Partner Content |
| Bionano Genomics acquires Lineagen for ~$9.6M Aug 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.59 |
| Today’s open | 0.57 |
| Day’s range | 0.57 - 0.64 |
| Volume | 11,018,847 |
| Average volume (3 months) | 19,435,201 |
| Market cap | $108.0M |
Data as of 3:59pm ET, 09/17/2020
Growth & Valuation
| Earnings growth (last year) | +23.84% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -15.59% |
| P/E ratio | NM |
| Price/Sales | 1.83 |
| Price/Book | 7.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XXII22nd Century Group I... | +0.00 | +0.46% |
| GNCAGenocea Biosciences ... | -0.20 | -7.30% |
| ETTXEntasis Therapeutics... | +0.01 | +0.34% |
| IMMPImmutep Ltd | 0.00 | 0.00% |
Data as of 6:37pm ET, 09/17/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $10.1M |
| Annual profit (last year) | -$29.8M |
| Net profit margin | -294.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
